Greg Davis
Medical Reporter-
Chances are you or someone close to you has been directly impacted by the opioid epidemic, which continues to afflict Kentucky. In 2021, overdose deaths in Kentucky reached an all-time high of 2,250, with 90% involving an opioid. Because bystanders are present in more than a third of opioid overdoses, hundreds of these deaths could have been prevented with naloxone, a lifesaving medication that is accessible, safe and easy to administer. Trish Freeman, a professor in the UK College of Pharmacy, talks with Greg about this potentially game-changing development in the fight against opioid addiction and overdose deaths.
-
The National Institutes of Health (NIH) awarded the University of Kentucky a prestigious center grant to share its expertise and lead national efforts to build diverse academic research environments. This will be accomplished by the oversight of the new Support of Research Excellence (SuRE) R16 grant program designed to foster research capacity building at colleges and universities that serve underrepresented students. Dr. Greg talks with program co-director Brett Spear.
-
Twenty years ago, Kentucky had the highest colorectal cancer incidence and mortality rates in the U.S., as well as the second-lowest colorectal cancer screening rate. That's certainly not the case now. Dr. Greg talks with Dr. Thomas Tucker, senior director for cancer surveillance at UK's Markey Cancer Center about the turnaround and where Kentucky goes from here.
-
The incidence of spinal cord injury is over 17,000 new cases per year in the United States. The University of Kentucky is home to the Spinal Cord Injury and Research Center which helps develop new treatment methods for those who experience such trauma. This week Dr. Greg talks with acting director John Gensel about the center and his takeaways from a national conference he recently attended on the issue.
-
Jill Kolesar, Pharm.D., a professor in UK’s College of Pharmacy and co-director of the UK Markey Cancer Center Molecular Tumor Board, is principal investigator of a study examining the impact molecular tumor board review has in cancer patient outcomes. She talks about it this week on Dr. Greg Davis on Medicine.
-
The University of Kentucky is a site for the groundbreaking AHEAD study, the first-ever clinical trial to test the effect of a promising drug known as lecanemab. Just a few weeks ago the U.S. Food and Drug Administration approved Leqembi (lecanemab-irmb) via the Accelerated Approval pathway for the treatment of Alzheimer’s disease. This represents an important advancement in the ongoing fight to effectively treat Alzheimer’s disease, and UK’s Sanders-Brown Center on Aging is on the forefront of the work. Dr. Greg speaks with Greg Jicha, director of clinical trials at UK’s Sanders-Brown Center on Aging.
-
Each year, a group of students and employees at the University of Kentucky College of Pharmacy and campus and community partners work together to show Lexington that science is all around us, not just in the research labs. Everything is Science is held at different locations throughout the city, with events happening Monday through Friday. The festival features presentations, demonstrations, and conversations in laid-back spaces, like local restaurants, pubs, and breweries. Speakers aim to bring an uncomplicated approach to topics that we may not initially consider science-related. Dr. Greg gets a preview from coordinating committee member Dr. Lou Hirsch.
-
University of Kentucky College of Public Health (CPH) researchers, in collaboration with investigators from the UK College of Medicine, the UK College of Communication and Information and the Kentucky Department for Public Health (KDPH), are leading a five-year, $3.7 million project to study COVID-19 vaccination hesitancy in Eastern Kentucky. Dr. Greg talks with co-principal investigator Marc T. Kiviniemi, Ph.D.
-
As the COVID-19 pandemic approaches the three year mark, University of Kentucky clinical microbiologist Dr. Vaneet Arora says both the virus - and the efforts to combat it - continue to evolve. Dr. Arora joins Greg for an update.
-
The quick action of athletic trainers is credited with saving the life of Buffalo Bills’ safety Damar Hamlin. This week on Dr. Greg Davis we take a deep dive into how athletic trainers are trained to respond to even the most unimaginable sports-related emergency situations. He goes one on one with Dr. Johanna Hoch, Program Director of the Professional Masters in Athletic Training at the University of Kentucky.